Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.10.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid- in Capital [Member]
Accumulated Deficit [Member]
Total
Beginning balance at Dec. 31, 2017 $ 24 $ 243,419 $ (138,043) $ 105,400
Beginning balance, shares at Dec. 31, 2017 24,275,000      
Sale of common shares and issuance of warrants, value $ 5 7,679 7,684
Sale of common shares and issuance of warrants 4,435,000      
Stock-based compensation 332 332
Convertible debt instruments $ 1 2,061 2,062
Convertible debt instruments, shares 1,085,000      
Exercise of common stock options 185 $ 185
Exercise of common stock options, shares 128,000     (128,000)
Net loss (4,762) $ (4,762)
Ending Balance at Sep. 30, 2018 $ 30 $ 253,676 $ (142,805) $ 110,901
Ending Balance, shares at Sep. 30, 2018 29,923,000